Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization

Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization

BackgroundTo evaluate the efficacy and safety of clopidogrel-rivaroxaban combination compared to aspirin-rivaroxaban combination in patients with symptomatic peripheral artery disease (PAD).MethodsConsecutive patients with symptomatic PAD patients were analyzed from January, 2018 to June, 2022 at Na...

Full description

Saved in:
Bibliographic Details
Main Authors: Min Lu, Jiaqi Li, Huanyu Ni, Tong Qiao, Baoyan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
peripheral artery disease
clopidogrel
rivaroxaban
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1485380/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items